Search All UT System Experts

Increasing the daily dose of recombinant follicle stimulating hormone (Puregon®) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation

Henk J. Out, Didi D.M. Braat, Bea M.E. Lintsen, Timur Gurgan, Orhan Bukulmez, Oya Gökmen, G#x00FC;rhan Keles, Pedro Caballero, José M. González, Francisco Fábregues, Juan Balasch, Roger Roulier

Research output: Contribution to journal › Article › peer-review

92 Scopus citations

Fingerprint

Dive into the research topics of 'Increasing the daily dose of recombinant follicle stimulating hormone (Puregon®) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation'. Together they form a unique fingerprint.

Medicine & Life Sciences